Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6066863 Target Snapshot

Alpha amylase · PROTEIN FAMILY · Homo sapiens

369Compounds
78Assays
2Approved Drugs
377.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P0DUB6. Use UniProt P0DUB6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P0DUB6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Alpha amylase as ChEMBL target CHEMBL6066863, mapped to UniProt P0DUB6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Alpha amylase
PROTEIN FAMILY · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL6066863
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P0DUB6
Alpha-amylase 1A
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Alpha amylase is the right protein anchor across sources, using UniProt P0DUB6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAlpha-amylase 1A
UniProt AccessionP0DUB6
Component TypeProtein
Sequence Length511 aa

Alpha-amylase 1A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Alpha amylase, mapped to UniProt P0DUB6. ChEMBL maps the protein component as Alpha-amylase 1A. Sequence length is 511 aa.

Mapped IDP0DUB6
Review nameAlpha amylase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
2
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50364.0
KI10.0
EC503.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3940413 8.7 EC50 2.0 Preclinical
CHEMBL3933500 8.52 EC50 3.0 Preclinical
CHEMBL5613512 8.52 EC50 3.0 Preclinical
CHEMBL5590766 7.4 IC50 39.9 Preclinical
CHEMBL5593047 7.35 IC50 44.77 Preclinical
CHEMBL5595096 7.32 IC50 48.08 Preclinical
CHEMBL5595111 7.32 IC50 47.97 Preclinical
CHEMBL5592906 7.31 IC50 49.32 Preclinical
CHEMBL5592459 7.28 IC50 52.97 Preclinical
CHEMBL5595454 7.27 IC50 53.95 Preclinical
Distribution

pChEMBL Value Distribution

60
5.0
98
5.5
28
6.0
15
6.5
25
7.0
0
7.5
0
8.0
3
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ACARBOSE
CHEMBL404271
Approved 1995
Assay Landscape

Assay Landscape

78
Total Assays
254
Tested Compounds
1
Assay Types
Binding — 78 assays, 254 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 64 197 5.5
protein format 10 52 5.7
tissue-based format 4 5 5.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine